FREE Account Opening + No Clearing Fees
Loading...
Shukra Pharmaceuticals Rights Issue 2023 Detail
Issue Open February 15, 2023
Issue Close February 28, 2023
Issue Size (Shares) 0.94 Crores
Issue Size (Amount) ₹18.79 Crores
Issue Price ₹20 per Share
Listing At BSE
  1. Life Sciences Procurement Update: FY2025 NDAA Would Changes to Rules of Origin for Drugs

    September 18, 2024 12:37:00 AM

    In July, the Senate Armed Services Committee passed its version of the FY 2025 National Defense Authorization Act (NDAA), which would make ...

    Published by : JD Supra
  2. Viatris 2023 Sustainability Report: Breaking Down Systemic Barriers To Access Through Policy Engagement

    September 10, 2024 7:48:00 PM

    We leverage our global experiences, scientific expertise and operations knowledge to support policymakers in identifying policies that advance access to quality medicines and build systems that ...

    Published by : CSR Wire
  3. FDA issues Form 483s to Japanese, Indian drugmakers in wake of plant inspections

    September 10, 2024 4:20:00 PM

    Two Japanese drugmakers and another in India were hit with Form 483s from the FDA following inspections that uncovered issues ranging from a lack of sanitary procedures to improper data collection and ...

    Published by : FiercePharma
  4. Nike shareholders vote against proposal on workers rights

    September 10, 2024 7:33:00 PM

    Nike shareholders have voted against a proposal to consider joining binding agreements with supply chain workers to better address human rights issues in high-risk countries at its annual meeting, the ...

    Published by : Reuters

Read Shukra Pharmaceuticals Rights Issue 2023 current news. Find Shukra Pharmaceuticals Rights Issue 2023 subscription news, Rights Issue analysis, broker reviews, allotment news, and listing date. Get the Shukra Pharmaceuticals Limited Rights Issue grey market premium and Shukra Pharmaceuticals Rights Issue 2023 expected listing price.